Combined Triple Therapy in Diabetic Retinopathy (DRP)
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The aim of this pilot study was to investigate the effects of an intravitreal combination
therapy using triamcinolone and bevacizumab in patients with macular edema due to diabetic
retinopathy.